| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.32B | +0.9% |
| Gross Profit | $4.45B | -3.1% |
| R&D Expense | $739.0M | -4.6% |
| SG&A Expense | $3.08B | +10.7% |
| Operating Income | $2.18B | +110.5% |
| Pre-tax Income | $1.71B | +183.1% |
| Income Tax | $157.0M | +23.6% |
| Net Income | $1.56B | +224.8% |
| EPS (Basic) | $8.94 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $878.0M | +15.2% |
| Accounts Receivable | $1.03B | -1.0% |
| Inventory | $1.07B | +10.5% |
| Current Assets | $3.86B | +18.8% |
| Total Assets | $14.29B | -1.1% |
| Current Liabilities | $3.14B | +16.0% |
| Long-term Debt | $5.04B | -37.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $369.0M | -68.9% |
| Capital Expenditures | $379.0M | -0.3% |
| Investing Cash Flow | $2.80B | +836.1% |
| Financing Cash Flow | -$3.06B | -1173.8% |
| Free Cash Flow | -$10.0M | -101.2% |
| +222.7% |
| EPS (Diluted) | $8.88 | +221.7% |
| Total Liabilities |
| $9.24B |
| -19.6% |
| Stockholders' Equity | $5.05B | +70.6% |